Dr. Frederick LANSIGAN, MD
Claim this profileDartmouth Hitchcock Medical Center
Area of expertise
Lymphoma
Frederick LANSIGAN, MD has run 5 trials for Lymphoma. Some of their research focus areas include:
Large B-Cell Lymphoma
Frederick LANSIGAN, MD has run 4 trials for Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Dartmouth-Hitchcock Medical Center
Clinical Trials Frederick LANSIGAN, MD is currently running
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting
2 awards
Phase 3
13 criteria
Venetoclax + Obinutuzumab
for Leukemia
This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with the venetoclax and obinutuzumab early (before patients have symptoms) may have better outcomes for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma compared to starting treatment with the venetoclax and obinutuzumab after patients show symptoms.
Recruiting
2 awards
Phase 3
1 criteria
More about Frederick LANSIGAN, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Frederick LANSIGAN, MD has experience with
- Rituximab
- Nivolumab
- Cyclophosphamide
- Doxorubicin Hydrochloride
- Lenalidomide
- Obinutuzumab
Breakdown of trials Frederick LANSIGAN, MD has run
Lymphoma
Large B-Cell Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Frederick LANSIGAN, MD specialize in?
Frederick LANSIGAN, MD focuses on Lymphoma and Large B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved 13q positive patients, or patients who are 13q negative.
Is Frederick LANSIGAN, MD currently recruiting for clinical trials?
Yes, Frederick LANSIGAN, MD is currently recruiting for 2 clinical trials in Lebanon New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Frederick LANSIGAN, MD has studied deeply?
Yes, Frederick LANSIGAN, MD has studied treatments such as Rituximab, Nivolumab, Cyclophosphamide.
What is the best way to schedule an appointment with Frederick LANSIGAN, MD?
Apply for one of the trials that Frederick LANSIGAN, MD is conducting.
What is the office address of Frederick LANSIGAN, MD?
The office of Frederick LANSIGAN, MD is located at: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756 United States. This is the address for their practice at the Dartmouth Hitchcock Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.